These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 18796313)

  • 1. Molecular targets for flavivirus drug discovery.
    Sampath A; Padmanabhan R
    Antiviral Res; 2009 Jan; 81(1):6-15. PubMed ID: 18796313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in flavivirus antiviral drug discovery and vaccine development.
    Ray D; Shi PY
    Recent Pat Antiinfect Drug Discov; 2006 Jan; 1(1):45-55. PubMed ID: 18221133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Role of Flavivirus NS2B-NS3 Proteases in Viral Pathogenesis and Anti-flavivirus Drug Discovery Employing Animal Cells and Models: A Review.
    Wahaab A; Mustafa BE; Hameed M; Stevenson NJ; Anwar MN; Liu K; Wei J; Qiu Y; Ma Z
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New developments in flavivirus drug discovery.
    Kok WM
    Expert Opin Drug Discov; 2016; 11(5):433-45. PubMed ID: 26966889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Flaviviruses by Targeting a Conserved Pocket on the Viral Envelope Protein.
    de Wispelaere M; Lian W; Potisopon S; Li PC; Jang J; Ficarro SB; Clark MJ; Zhu X; Kaplan JB; Pitts JD; Wales TE; Wang J; Engen JR; Marto JA; Gray NS; Yang PL
    Cell Chem Biol; 2018 Aug; 25(8):1006-1016.e8. PubMed ID: 29937406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Many Faces of the Flavivirus NS5 Protein in Antagonism of Type I Interferon Signaling.
    Best SM
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipids and flaviviruses, present and future perspectives for the control of dengue, Zika, and West Nile viruses.
    Martín-Acebes MA; Vázquez-Calvo Á; Saiz JC
    Prog Lipid Res; 2016 Oct; 64():123-137. PubMed ID: 27702593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flavivirus enzymes and their inhibitors.
    Knyazhanskaya E; Morais MC; Choi KH
    Enzymes; 2021; 49():265-303. PubMed ID: 34696835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel approaches to flavivirus drug discovery.
    Botting C; Kuhn RJ
    Expert Opin Drug Discov; 2012 May; 7(5):417-28. PubMed ID: 22439769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focus on flaviviruses: current and future drug targets.
    Geiss BJ; Stahla H; Hannah AM; Gari AM; Keenan SM
    Future Med Chem; 2009 May; 1(2):327-44. PubMed ID: 20165556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Insights into the Flavivirus Replication Complex.
    van den Elsen K; Quek JP; Luo D
    Viruses; 2021 May; 13(6):. PubMed ID: 34064113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Akt Kinase Intervenes in Flavivirus Replication by Interacting with Viral Protein NS5.
    Albentosa-González L; Jimenez de Oya N; Arias A; Clemente-Casares P; Martin-Acebes MÁ; Saiz JC; Sabariegos R; Mas A
    Viruses; 2021 May; 13(5):. PubMed ID: 34066055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of host cell factors in flavivirus infection: Implications for pathogenesis and development of antiviral drugs.
    Pastorino B; Nougairède A; Wurtz N; Gould E; de Lamballerie X
    Antiviral Res; 2010 Sep; 87(3):281-94. PubMed ID: 20452379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of RNA-binding proteins during the late stages of Flavivirus replication cycle.
    Diosa-Toro M; Prasanth KR; Bradrick SS; Garcia Blanco MA
    Virol J; 2020 Apr; 17(1):60. PubMed ID: 32334603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine inhibits flavivirus replication through blocking the interaction between host cyclophilins and viral NS5 protein.
    Qing M; Yang F; Zhang B; Zou G; Robida JM; Yuan Z; Tang H; Shi PY
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3226-35. PubMed ID: 19451286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The flavivirus protease as a target for drug discovery.
    Brecher M; Zhang J; Li H
    Virol Sin; 2013 Dec; 28(6):326-36. PubMed ID: 24242363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleic acid-based inhibition of flavivirus infections.
    Stein DA; Shi PY
    Front Biosci; 2008 Jan; 13():1385-95. PubMed ID: 17981637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antiviral activity of adenosine analog NITD008 against tick-borne flaviviruses.
    Lo MK; Shi PY; Chen YL; Flint M; Spiropoulou CF
    Antiviral Res; 2016 Jun; 130():46-9. PubMed ID: 27016316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Finding new medicines for flaviviral targets.
    Keller TH; Chen YL; Knox JE; Lim SP; Ma NL; Patel SJ; Sampath A; Wang QY; Yin Z; Vasudevan SG
    Novartis Found Symp; 2006; 277():102-14; discussion 114-9, 251-3. PubMed ID: 17319157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythrosin B is a potent and broad-spectrum orthosteric inhibitor of the flavivirus NS2B-NS3 protease.
    Li Z; Sakamuru S; Huang R; Brecher M; Koetzner CA; Zhang J; Chen H; Qin CF; Zhang QY; Zhou J; Kramer LD; Xia M; Li H
    Antiviral Res; 2018 Feb; 150():217-225. PubMed ID: 29288700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.